Hubei Biocause Pharmaceutical (000627) — Cash Flow Quality Index

Latest as of March 2023: 135.70x

Hubei Biocause Pharmaceutical (000627) has a Cash Flow Quality Index of 135.70x as of March 2023. Operating cash flow of CN¥6.13 Billion exceeds net income of CN¥45.21 Million, indicating high earnings quality where cash backs reported profits. Explore 000627 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

135.70x
Operating CF / Net Income

Operating Cash Flow

CN¥6.13 Billion
CNY

Net Income

CN¥45.21 Million
CNY

Data as of

Mar 2023
Most recent filing

Hubei Biocause Pharmaceutical Cash Flow Quality Index (2001–2022)

Historical Cash Flow Quality Index for Hubei Biocause Pharmaceutical across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hubei Biocause Pharmaceutical (000627) cash flow conversion.

Annual Cash Flow Quality Index for Hubei Biocause Pharmaceutical (2001–2022)

Year-by-year earnings quality comparison for Hubei Biocause Pharmaceutical.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2022 27.46x CN¥7.52 Billion CN¥274.05 Million ▲ +209.7%
2021 8.86x CN¥4.17 Billion CN¥470.71 Million ▼ -76.0%
2020 36.91x CN¥21.42 Billion CN¥580.29 Million ▲ +129.2%
2019 16.10x CN¥28.60 Billion CN¥1.78 Billion ▲ +42.6%
2018 11.29x CN¥14.98 Billion CN¥1.33 Billion ▲ +3370.4%
2017 0.33x CN¥431.58 Million CN¥1.33 Billion ▲ +124.7%
2016 -1.32x CN¥-2.34 Billion CN¥1.78 Billion ▼ -596.8%
2015 -0.19x CN¥-46.73 Million CN¥247.27 Million ▼ -102.4%
2012 7.93x CN¥93.79 Million CN¥11.82 Million ▲ +0.0%
2010 7.93x CN¥224.58 Million CN¥28.32 Million ▲ +569.2%
2007 1.19x CN¥118.56 Million CN¥100.05 Million ▼ -55.3%
2006 2.65x CN¥128.19 Million CN¥48.37 Million ▼ -61.3%
2005 6.85x CN¥48.66 Million CN¥7.10 Million ▼ -37.8%
2004 11.01x CN¥56.07 Million CN¥5.09 Million ▲ +999.2%
2001 1.00x CN¥37.30 Million CN¥37.23 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.